OFS
BBH icon

Orrstown Financial Services’s VanEck Biotech ETF BBH Stock Holding History

Orrstown Financial Services’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-100
Closed -$13K – 205
2015
Q4 		$13K Hold
100
– – 0.01% 141
2015
Q3 		$11K Buy
+100
New +$13.2K 0.01% 155

Other funds holding BBH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return

Orrstown Financial Services's BBH Position: Q1 2016 in Review

Orrstown Financial Services sold out of VanEck Biotech ETF (BBH) in Q1 2016, closing a stake of 100 shares — an estimated $13K sold.

Orrstown Financial Services first reported a position in BBH in Q3 2015 and held it in 2 quarters. The position peaked at $13K in Q4 2015. 71 funds tracked by Wall St. Rank hold BBH as of Q1 2016.

  • Orrstown Financial Services reported no remaining VanEck Biotech ETF position as of Q1 2016 after selling out during the quarter.
  • Orrstown Financial Services sold 100 VanEck Biotech ETF shares in Q1 2016, an estimated $13K.
  • Orrstown Financial Services first reported a position in VanEck Biotech ETF in Q3 2015 and held it in 2 quarters.
  • Orrstown Financial Services's VanEck Biotech ETF position peaked at $13K in Q4 2015.
  • 71 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2016.

Based on Orrstown Financial Services's 13F filing for Q1 2016, filed 8 Apr 2016.